Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
Autor: | D. Haase, A.A.N. Giagounidis, Martin Bornhäuser, Friederike Braulke, Gerhard Ehninger, Uwe Platzbecker, Ralph Naumann, Martin Wermke, Gesine Bug, Katayoon Shirneshan, Katharina Götze, Neesen J, Christoph Röllig, W.-K. Hofmann, Andrea Kündgen, Ulrich Germing, Claudia Schönefeldt |
---|---|
Rok vydání: | 2013 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Myeloid business.industry Myelodysplastic syndromes Azacitidine Myeloid leukemia Hematology medicine.disease Clinical trial Thalidomide Leukemia medicine.anatomical_structure hemic and lymphatic diseases Internal medicine medicine business medicine.drug Lenalidomide |
Zdroj: | Leukemia. 27:1403-1407 |
ISSN: | 1476-5551 0887-6924 |
DOI: | 10.1038/leu.2013.26 |
Popis: | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
Databáze: | OpenAIRE |
Externí odkaz: |